Akademik Veri Yönetim Sistemi
SENDROM, cilt.15, sa.4, ss.96-100, 2003 (Scopus)
Deep venous thrombosis (DVT) is a common and potentially life-threatening condition that can result in pulmonary embolism (PE) in nearly one third of the patients. Timely management of the patients suspected to have the entity helps to reduce local and thromboembolic complications leading to substantial morbidity and mortality. Half of the population with verified DVT is detected to harbor PE and thus anticoagulation should be promptly administered to these patients. Main goals of treatment of DVT are to prevent pulmonary embolism, to reduce mortality and to alleviate the risk of postphlebitic syndrome. Proper analgesia and early mobilization should be instituted following adequate anticoagulation with heparine. Warfarine should be ordered orally concurrent with heparine treatment. If low molecular weight heparine (LMWH) is not readily available or warfarine blood level is not satisfactory then infusion of unfractionated heparine is an alternative modality. Vena cava filters effectively prevent PE in more than 60% of the cases, with free iliofemoral thrombi larger than 5 cm Thrombectomy in conjunction with heparinization is recommended in cases who can not be treated with modalities of proven efficacy.